Biofargo News & Blog

Maximizing NGS Library Yields: Uncompromised Biotin Capture High-efficiency biotinylated nucleic acid capture for reproducible NGS workflows. In NGS workflows, target capture efficiency directly determines library yield, sequencing depth, and overall experimental success....

Eliminating False Positives: Achieving 96.83% Specificity in Oncology Diagnostics Reducing background interference and enabling high-confidence clinical detection. In clinical oncology diagnostics, specificity is critical. False positives can lead to severe misdiagnosis and...

Pushing the Limits of Detection: 2× Signal Amplification with Leadonano™ Streptavidin Beads Enhancing assay sensitivity and expanding detection limits in chemiluminescence immunoassays. For diagnostic assay developers, pushing detection limits while maintaining low...

Next-Generation cfDNA Isolation: Precision Meets Scalability with Biofargo In the rapidly evolving landscape of liquid biopsy and clinical oncology, the ability to isolate ultra-low abundance circulating cell-free DNA (cfDNA) is the cornerstone...

Haemophilus influenzae: Pathogenesis and qPCR Detection Overview Haemophilus influenzae is a Gram-negative pathogen commonly residing in the human respiratory tract. Despite its misleading name, it is not related to influenza virus but...

Legionella pneumophila: Pathogenesis and qPCR Detection Overview Legionella pneumophila is a Gram-negative, flagellated, short rod-shaped bacterium belonging to the genus Legionella. It is the primary causative agent of Legionnaires’ disease, a severe...